BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

7:34 PM
 | 
Feb 19, 2009
 |  BC Extra  |  Company News

Eisai licenses Zebinix from Bial-Portela

Bial-Portela (S. Mamede do Coronado, Portugal) granted Eisai (Tokyo:4523; Osaka:4523) exclusive rights to market Zebinix eslicarbazepine in Europe. On Thursday, the sodium...

Read the full 100 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >